Selank: The Tuftsin-Related Anxiolytic Heptapeptide
Research compounds for laboratory use only · not medical advice
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) and its research in anxiolytic and nootropic models, serotonin/dopamine modulation and GABAergic signaling.
Selank comes from a place most research peptides don’t: it was deliberately built around an immune peptide. Its sequence descends from tuftsin, a natural immunomodulatory tetrapeptide, which is why its research profile spans both the nervous system and inflammatory signaling.
The molecule
Selank is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro (C₃₃H₅₇N₁₁O₉, ≈ 752 g/mol). The first four residues are tuftsin (Thr-Lys-Pro-Arg), and the extension was designed to stabilize it against enzymatic degradation — a common trick in synthetic peptide development.
What the research looks at
Selank research clusters around three threads:
- Anxiolytic and nootropic effects — studied in behavioral models of anxiety and cognitive performance, with an unusual absence of sedation at tested doses
- Monoamine system modulation — serotonin and dopamine signaling are recurring points of investigation
- Inflammatory-cytokine balance — the tuftsin lineage makes immune-cytokine interaction a distinctive research angle for a peptide studied in the CNS
Because it shares design lineage with Semax, the two are frequently studied as a pair — the Semax page covers the cognitive arm.
Handling notes
Lyophilized, reconstitute with bacteriostatic water; the reconstitution calculator handles the math. Store at −20°C lyophilized.
See Selank for CAS, purity and full specifications.
For laboratory research use only. Not medical advice.
Last updated September 9, 2026
FAQ
Frequently asked questions
What is Selank?
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) structurally related to tuftsin, developed in Russia and studied for anxiolytic and nootropic effects.
How does Selank relate to Semax?
Both are synthetic Russian research peptides studied for CNS effects — Selank for anxiety modulation and Semax for cognitive enhancement. They are sometimes studied together as a cognitive panel.
What pathways does Selank research examine?
Serotonin and dopamine system modulation, GABAergic signaling, inflammatory-cytokine balance, and peptide-based anxiolytic development.
Keep reading
Related articles
AOD-9604: The hGH Fragment 177-191 Lipolytic Peptide
AOD-9604, the synthetic analog of hGH fragment 177-191, and its research in lipolysis, fat metabolism and growth-hormone fragment pharmacology.
BPC-157 Dosage and Reconstitution Math: 5 mg Vial in the Lab
BPC-157 vial math — reconstituting a 5 mg lyophilized vial, mg to mL and U-100 unit conversions, and common research dose ranges.
CJC-1295 No DAC (Mod GRF 1-29): The Short-Acting GHRH Analog
CJC-1295 No DAC (Modified GRF 1-29), the tetrasubstituted GHRH analog with DPP-IV resistance, and its research in GH-secretagogue and pulsatility studies.
Laboratory tools
Put it into practice
From the catalog
Reference compounds
HGH 191aa
Recombinant human growth hormone. Full 191aa sequence.
CAS 12629-01-5
10IU vial · In stock

NAD+
Nicotinamide adenine dinucleotide. Cellular metabolism studies.
CAS 53-84-9
500mg vial · In stock

GHK-Cu
Copper tripeptide-1. Tissue regeneration studies.
CAS 49557-75-7
50mg vial · In stock

TB-500
Thymosin β4 fragment. Actin-binding domain active.
CAS 885340-08-9
5mg vial · In stock
For laboratory research use only